Citations (53)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Soon Tjin Lim, Catherine A. Coughlan, Stephen J. X. Murphy, Israel Fernandez-Cadenas, Joan Montaner, Vincent Thijs, Lars Marquardt & Dominick J. H. McCabe. (2015) Platelet function testing in transient ischaemic attack and ischaemic stroke: A comprehensive systematic review of the literature. Platelets 26:5, pages 402-412.
Read now
Read now
Matthew D. Linden & Huyen A. Tran. (2012) Overcoming aspirin treatment failure in diabetes. Critical Reviews in Clinical Laboratory Sciences 49:5-6, pages 183-198.
Read now
Read now
Mehmet Akif Topçuoglu, Ethem Murat Arsava & Hakan Ay. (2011) Antiplatelet resistance in stroke. Expert Review of Neurotherapeutics 11:2, pages 251-263.
Read now
Read now
Paul Harrison, Helen Segal, Louise Silver, Anila Syed, Fiona C. Cuthbertson & Peter M. Rothwell. (2008) Lack of reproducibility of assessment of aspirin responsiveness by optical aggregometry and two platelet function tests. Platelets 19:2, pages 119-124.
Read now
Read now
Articles from other publishers (49)
S.T. Lim, S.J.X. Murphy, S.M. Murphy, T. Coughlan, D. O'Neill, S. Tierney, B. Egan, D.R. Collins, A.J. McCarthy, S.-Y. Lim, D.R. Smith, D. Cox & D.J.H. McCabe. (2022) Assessment of on-treatment platelet reactivity at high and low shear stress and platelet activation status after the addition of dipyridamole to aspirin in the early and late phases after TIA and ischaemic stroke. Journal of the Neurological Sciences 441, pages 120334.
Crossref
Crossref
Arun Subramanian, Siobhan Delaney, Stephen J.X. Murphy, Deirdre R. Smith, Chika Offiah, Jean McMahon, Gert J. de Borst, A. Ross Naylor, George Hamilton, Justin A. Kinsella & Dominick J.H. McCabe. (2022) Platelet Biomarkers in Patients with Atherosclerotic Extracranial Carotid Artery Stenosis: A Systematic Review. European Journal of Vascular and Endovascular Surgery 63:3, pages 379-389.
Crossref
Crossref
Stephen J Murphy, Soon T Lim, Justin A Kinsella, Sean Tierney, Bridget Egan, Tim M Feeley, Clare Dooley, James Kelly, Sinead M Murphy, Richard A Walsh, Ronan Collins, Tara Coughlan, Desmond O’Neill, Joseph A Harbison, Prakash Madhavan, Sean M O’Neill, Mary P Colgan, Jim F Meaney, George Hamilton & Dominick JH McCabe. (2019) Simultaneous assessment of plaque morphology, cerebral micro-embolic signal status and platelet biomarkers in patients with recently symptomatic and asymptomatic carotid stenosis. Journal of Cerebral Blood Flow & Metabolism 40:11, pages 2201-2214.
Crossref
Crossref
Soon Tjin Lim, Vincent Thijs, Stephen J. X. Murphy, Israel Fernandez-Cadenas, Joan Montaner, Chika Offiah, Lars Marquardt, Peter J. Kelly, Philip M. Bath, Su-Yin Lim, Gary A. Ford, Bo Norrving, Dermot Cox, Calin I. Prodan, Philip A. Barber, David J. Werring, Richard Perry, Lina Zgaga, Jesse Dawson & Dominick J. H. McCabe. (2020) Platelet function/reactivity testing and prediction of risk of recurrent vascular events and outcomes after TIA or ischaemic stroke: systematic review and meta-analysis. Journal of Neurology 267:10, pages 3021-3037.
Crossref
Crossref
Vafa Alakbarzade, Xuya Huang, Irina Chis Ster, Meriel McEntagart & Anthony C. Pereira. (2020) High on-clopidogrel platelet reactivity in ischaemic stroke or transient ischaemic attack: Systematic review and meta-analysis. Journal of Stroke and Cerebrovascular Diseases 29:7, pages 104877.
Crossref
Crossref
A.R. Naylor & D.J.H. McCabe. (2020) New Data and the Covid-19 Pandemic Mandate a Rethink of Antiplatelet Strategies in Patients With TIA or Minor Stroke Associated With Atherosclerotic Carotid Stenosis. European Journal of Vascular and Endovascular Surgery 59:6, pages 861-865.
Crossref
Crossref
Adam Wiśniewski, Joanna Sikora, Agata Sławińska, Karolina Filipska, Aleksandra Karczmarska-Wódzka, Zbigniew Serafin & Grzegorz Kozera. (2020) High On-Treatment Platelet Reactivity Affects the Extent of Ischemic Lesions in Stroke Patients Due to Large-Vessel Disease. Journal of Clinical Medicine 9:1, pages 251.
Crossref
Crossref
S. J. X. Murphy, S. T. Lim, J. A. Kinsella, S. Tierney, B. Egan, T. M. Feeley, S. M. Murphy, R. A. Walsh, D. R. Collins, T. Coughlan, D. O’Neill, J. A. Harbison, P. Madhavan, S. M. O’Neill, M. P. Colgan, D. Cox, N. Moran, G. Hamilton, J. F. Meaney & D. J. H. McCabe. (2019) Relationship between ‘on-treatment platelet reactivity’, shear stress, and micro-embolic signals in asymptomatic and symptomatic carotid stenosis. Journal of Neurology 267:1, pages 168-184.
Crossref
Crossref
Xiaolan Zheng, Wenchao Wu, Yi Zhang & Gang Wu. (2019) Changes in and significance of platelet function and parameters in Kawasaki disease. Scientific Reports 9:1.
Crossref
Crossref
Kevin P. Bliden, Gabe Raviv, Udaya S. Tantry, Rahul Chaudhary, John W. Cochran, Eliano P. Navarese, Tricia Brannan, Ankit Vyas & Paul A. Gurbel. (2019) “Blueprinting” thrombogenicity and antithrombotic drug response at the bedside in patients presenting emergently with symptoms of acute stroke. Journal of Thrombosis and Thrombolysis 47:2, pages 192-199.
Crossref
Crossref
Kate Navaratnam, Zarko Alfirevic, Munir Pirmohamed & Ana Alfirevic. (2017) How important is aspirin adherence when evaluating effectiveness of low-dose aspirin?. European Journal of Obstetrics & Gynecology and Reproductive Biology 219, pages 1-9.
Crossref
Crossref
Xuan Cheng, Nan-Chang Xie, Hong-Liang Xu, Chen Chen & Ya-Jun Lian. (2017) Biochemical aspirin resistance is associated with increased stroke severity and infarct volumes in ischemic stroke patients. Oncotarget 8:44, pages 77086-77095.
Crossref
Crossref
Justin A Kinsella, W Oliver Tobin, Sean Tierney, Timothy M Feeley, Bridget Egan, Tara Coughlan, D Ronan Collins, Desmond O'Neill, Joseph A Harbison, Colin P Doherty, Prakash Madhavan, Dermot J Moore, Sean M O'Neill, Mary-Paula Colgan, Maher Saqqur, Raymond P Murphy, Niamh Moran, George Hamilton & Dominick J H McCabe. (2017) Assessment of ‘on-treatment platelet reactivity’ and relationship with cerebral micro-embolic signals in asymptomatic and symptomatic carotid stenosis. Journal of the Neurological Sciences 376, pages 133-139.
Crossref
Crossref
Claire Pearson, Karin Przyklenk, Valerie H. Mika, Syed Imran Ayaz, Morgan Ellis, Preet Varade, Rosa Tolomello & Robert D. Welch. (2017) Utility of point of care assessment of platelet reactivity (using the PFA-100®) to aid in diagnosis of stroke. The American Journal of Emergency Medicine 35:5, pages 802.e1-802.e5.
Crossref
Crossref
WO Tobin, JA Kinsella, GF Kavanagh, JS O'Donnell, RT McGrath, S Tierney, B Egan, TM Feeley, T Coughlan, DR Collins, D O'Neill, SJX Murphy, SJ Lim, RP Murphy & DJH McCabe. (2017) Profile of von Willebrand factor antigen and von Willebrand factor propeptide in an overall TIA and ischaemic stroke population and amongst subtypes. Journal of the Neurological Sciences 375, pages 404-410.
Crossref
Crossref
J.-S. Doly, E. Lorian, I. Desormais, J. Constans, A. Bura Rivière & P. Lacroix. (2016) Prévalence et valeur pronostique de la résistance à l’aspirine chez les patients en ischémie critique chronique des membres inférieurs. Journal des Maladies Vasculaires 41:6, pages 358-364.
Crossref
Crossref
Joon-Tae KimSuk-Hee HeoKang-Ho ChoiTai-Seung NamSeong-Min ChoiSeung-Han LeeMan-Seok ParkByeong C. KimMyeong-Kyu KimJeffrey L. SaverKi-Hyun Cho. (2015) Clinical Implications of Changes in Individual Platelet Reactivity to Aspirin Over Time in Acute Ischemic Stroke. Stroke 46:9, pages 2534-2540.
Crossref
Crossref
Janine Dretzke, Richard D Riley, Marie Lordkipanidzé, Susan Jowett, Jennifer O’Donnell, Joie Ensor, Eoin Moloney, Malcolm Price, Smriti Raichand, James Hodgkinson, Susan Bayliss, David Fitzmaurice & David Moore. (2015) The prognostic utility of tests of platelet function for the detection of ‘aspirin resistance’ in patients with established cardiovascular or cerebrovascular disease: a systematic review and economic evaluation. Health Technology Assessment 19:37, pages 1-366.
Crossref
Crossref
Joon-Tae Kim, Suk-Hee Heo, Ji Sung Lee, Min-Ji Choi, Kang-Ho Choi, Tai-Seung Nam, Seung-Han Lee, Man-Seok Park, Byeong C. Kim, Myeong-Kyu Kim & Ki-Hyun Cho. (2015) Aspirin Resistance in the Acute Stages of Acute Ischemic Stroke Is Associated with the Development of New Ischemic Lesions. PLOS ONE 10:4, pages e0120743.
Crossref
Crossref
Azza A. Eltayeb, Gamal A. Askar, Naglaa H. Abu Faddan & Taghreed M. Kamal. (2015) Prothrombotic risk factors and antithrombotic therapy in children with ischemic stroke. Therapeutic Advances in Neurological Disorders 8:2, pages 71-81.
Crossref
Crossref
Dominick J.H. McCabe, Stephen J.X. Murphy, Richard Starke, Paul Harrison, Martin M. Brown, Paul S. Sidhu, Ian J. Mackie, Marie Scully & Samuel J. Machin. (2015) Relationship between ADAMTS13 activity, von Willebrand factor antigen levels and platelet function in the early and late phases after TIA or ischaemic stroke. Journal of the Neurological Sciences 348:1-2, pages 35-40.
Crossref
Crossref
J. A. Kinsella, W. O. Tobin, G. F. Kavanagh, J. S. O'Donnell, R. T. McGrath, S. Tierney, T. M. Feeley, B. Egan, D. O'Neill, R. D. Collins, T. Coughlan, J. A. Harbison, C. P. Doherty, P. Madhavan, D. J. Moore, S. M. O'Neill, M.-P. Colgan, M. Saqqur, R. P. Murphy, N. Moran, G. Hamilton & D. J. H. McCabe. (2014) Increased endothelial activation in recently symptomatic versus asymptomatic carotid artery stenosis and in cerebral microembolic-signal-negative patient subgroups. European Journal of Neurology 21:7, pages 969-e55.
Crossref
Crossref
W. O. Tobin, J. A. Kinsella, G. F. Kavanagh, J. S. O’Donnell, R. T. McGrath, T. Coughlan, D. R. Collins, D. O’Neill, B. Egan, S. Tierney, T. M. Feeley, R. P. Murphy & D. J. H. McCabe. (2014) Longitudinal assessment of von Willebrand factor antigen and von Willebrand factor propeptide in response to alteration of antiplatelet therapy after TIA or ischaemic stroke. Journal of Neurology 261:7, pages 1405-1412.
Crossref
Crossref
Matthew D. Linden. (2013) Using Platelet Function Testing to Guide Antiplatelet Therapy. Drug Development Research 74:8, pages 517-525.
Crossref
Crossref
Nalyaka Sambu, Ashwin Radhakrishnan, Nicola Englyst, Nicolas Weir & Nick Curzen. (2013) “Aspirin Resistance” in Ischemic Stroke: Insights Using Short Thrombelastography. Journal of Stroke and Cerebrovascular Diseases 22:8, pages 1412-1419.
Crossref
Crossref
Justin A. Kinsella, W. Oliver Tobin, Dermot Cox, Tara Coughlan, Ronan Collins, Desmond O’Neill, Raymond P. Murphy & Dominick J.H. McCabe. (2013) Prevalence of Ex Vivo High On-treatment Platelet Reactivity on Antiplatelet Therapy after Transient Ischemic Attack or Ischemic Stroke on the PFA-100® and VerifyNow®. Journal of Stroke and Cerebrovascular Diseases 22:7, pages e84-e92.
Crossref
Crossref
J. A. Kinsella, W. O. Tobin, G. Hamilton & D. J. H. McCabe. (2012) Platelet Activation, Function, and Reactivity in Atherosclerotic Carotid Artery Stenosis: A Systematic Review of the Literature. International Journal of Stroke 8:6, pages 451-464.
Crossref
Crossref
Pornpatr A. Dharmasaroja, Sombat Muengtaweepongsa & Suvaraporn Sae-Lim. (2013) Aspirin nonresponders in patients with ischaemic stroke. Blood Coagulation & Fibrinolysis 24:4, pages 361-364.
Crossref
Crossref
W. O. Tobin, J. A. Kinsella, T. Coughlan, D. R. Collins, D. O'Neill, R. P. Murphy, B. Egan, S. Tierney, T. M. Feeley & D. J. H. McCabe. (2012)
High on‐treatment platelet reactivity on commonly prescribed antiplatelet agents following transient ischaemic attack or ischaemic stroke: results from the
T
rinity Antiplatelet Responsiveness (
TRAP
) study
. European Journal of Neurology 20:2, pages 344-352.
Crossref
Crossref
W. O. Tobin, J. A. Kinsella, G. F. Kavanagh, J. S. O’Donnell, R. A. McGrath, D. R. Collins, T. Coughlan, D. O’Neill, B. Egan, S. Tierney, T. M. Feeley, R. P. Murphy & Dominick J. H. McCabe. (2012) Longitudinal assessment of thrombin generation potential in response to alteration of antiplatelet therapy after TIA or ischaemic stroke. Journal of Neurology 260:2, pages 590-596.
Crossref
Crossref
Robert C. Block, Lisa Kakinami, Matthew Jonovich, Illena Antonetti, Peter Lawrence, Nida Meednu, Pedro CalderonArtero, Shaker A. Mousa, J. Thomas Brenna & Steve Georas. (2012) The combination of EPA+DHA and low-dose aspirin ingestion reduces platelet function acutely whereas each alone may not in healthy humans. Prostaglandins, Leukotrienes and Essential Fatty Acids 87:4-5, pages 143-151.
Crossref
Crossref
Ping-Tsun Lai, Shu-Yi Chen, Yu-Sun Lee, Yu-Ping Ho, Yi-Ying Chiang & Hung-Yi Hsu. (2012) Relationship between acute stroke outcome, aspirin resistance, and humoral factors. Journal of the Chinese Medical Association 75:10, pages 513-518.
Crossref
Crossref
Saskia H. Meves, Ursula Overbeck, Heinz G. Endres, Christos Krogias & Horst Neubauer. (2017) Dose-dependent effect of early antiplatelet therapy in acute ischaemic stroke. Thrombosis and Haemostasis 107:01, pages 69-79.
Crossref
Crossref
Serkan Ozben, Beste Ozben, Azra Meryem Tanrikulu, Feriha Ozer & Tomris Ozben. (2011) Aspirin resistance in patients with acute ischemic stroke. Journal of Neurology 258:11, pages 1979-1986.
Crossref
Crossref
Jesse Dawson, Terry Quinn, Mark Rafferty, Peter Higgins, Gautamanda Ray, Kennedy R. Lees & Matthew R. Walters. (2011) Aspirin Resistance and Compliance with Therapy. Cardiovascular Therapeutics 29:5, pages 301-307.
Crossref
Crossref
William Oliver Tobin, Justin A. Kinsella, Daniel Ronan Collins, Tara Coughlan, Desmond O’Neill, Bridget Egan, Sean Tierney, Thomas Martin Feeley, Raymond P. Murphy & Dominick J. H. McCabe. (2011) Enhanced ex vivo inhibition of platelet function following addition of dipyridamole to aspirin after transient ischaemic attack or ischaemic stroke: First results from the TRinity AntiPlatelet responsiveness (TrAP) study. British Journal of Haematology 152:5, pages 640-647.
Crossref
Crossref
Paul Harrison. (2010) The influence of citrate concentrations on PFA-100 closure times, platelet hyper-reactivity and aspirin monitoring. Thrombosis Research 126:2, pages e137-e138.
Crossref
Crossref
Jawahar L Mehta. (2010) Aspirin resistance: Fact or fiction? A point of view. World Journal of Cardiology 2:9, pages 280.
Crossref
Crossref
T.J. KUNICKI, S.A. WILLIAMS, D.R. SALOMON, P. HARRISON, P. CRISLER, P. NAKAGAWA, T.S. MONDALA, S.R. HEAD & D.J. NUGENT. (2009) Genetics of platelet reactivity in normal, healthy individuals. Journal of Thrombosis and Haemostasis 7:12, pages 2116-2122.
Crossref
Crossref
George Kasotakis, Iraklis I. Pipinos & Thomas G. Lynch. (2009) Current evidence and clinical implications of aspirin resistance. Journal of Vascular Surgery 50:6, pages 1500-1510.
Crossref
Crossref
Sofie S. Hedegaard, Anne-Mette Hvas, Erik L. Grove, Jens Refsgaard, Bianca Rocca, Giovanni Daví & Steen D. Kristensen. (2009) Optical platelet aggregation versus thromboxane metabolites in healthy individuals and patients with stable coronary artery disease after low-dose aspirin administration. Thrombosis Research 124:1, pages 96-100.
Crossref
Crossref
Giorgio B. Boncoraglio, Antonella Bodini, Carla Brambilla, Elena Corsini, Maria R. Carriero & Eugenio A. Parati. (2009) Aspirin resistance determined with PFA-100 does not predict new thrombotic events in patients with stable ischemic cerebrovascular disease. Clinical Neurology and Neurosurgery 111:3, pages 270-273.
Crossref
Crossref
Deepak Thomas & Robert P Giugliano. (2008) Antiplatelet Therapy in Early Management of Non-ST-segment Elevation Acute Coronary Syndrome: The 2002 and 2007 Guidelines From North America and Europe. Journal of Cardiovascular Pharmacology 51:5, pages 425-433.
Crossref
Crossref
Argirios E. Tsantes, Georgios Mantzios, Vassiliki Giannopoulou, Panagiotis Tsirigotis, Stefanos Bonovas, Evdoxia Rapti, Elissavet Mygiaki, Zafirios Kartasis, Nikolaos M. Sitaras, John Dervenoulas & Anthi Travlou. (2008) Monitoring aspirin treatment in patients with thrombocytosis: Comparison of the platelet function analyzer (PFA)-100 with optical aggregometry. Thrombosis Research 123:1, pages 100-107.
Crossref
Crossref
Paul Harrison, A.L. FrelingerIIIIII, Mark I. Furman & Alan D. Michelson. (2007) Measuring antiplatelet drug effects in the laboratory. Thrombosis Research 120:3, pages 323-336.
Crossref
Crossref
John L. Francis. 2007. Platelets. Platelets
519
534
.
Paul Harrison & David Keeling. 2007. Platelets. Platelets
445
474
.
Francesco Violi & Pasquale Pignatelli. (2006) Aspirin resistance: is this term meaningful?. Current Opinion in Hematology 13:5, pages 331-336.
Crossref
Crossref
Paul Harrison, Ian Mackie, Anthony Mathur, Monique SC Robinson, Ying Hong, Jorge D Erusalimsky, Samuel J Machin & John F Martin. (2005) Platelet hyper-function in acute coronary syndromes. Blood Coagulation & Fibrinolysis 16:8, pages 557-562.
Crossref
Crossref